melanotan-2 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-08-21. Numbers and descriptions here follow the published literature rather than marketing material.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Free base; salt forms differ |
| Molecular weight | Approximately 1024 g/mol | Calculated for the free base |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water and polar solvents | Poorly soluble in non-polar solvents |
| Typical storage | -20 degrees Celsius, dry, protected from light | Refers to the solid form |
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Retention time supports identity, while the mass spectrum confirms the molecular weight of the intact peptide. Purity is frequently reported as a percentage of total peak area, a figure that depends on the wavelength, column and gradient used. Impurity profiling may also look for truncated sequences, oxidised forms and residual counterions. Amino acid analysis and peptide mapping provide orthogonal confirmation when required.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
== History == Flupirtine was discovered and developed between the 1970s and the 1990s by Chemiewerk Homburg in Frankfurt am Main, Germany, which became Degussa Pharma Group and then through mergers, ASTA Pharma and Asta Medica. Retigabine, a bioisostere of flupirtine, was discovered as part of the same program and has a similar mechanism of action. Flupirtine was approved for the treatment of pain in 1984 in Europe under the brand name Katadolon. As of 2013 it was used in 11 member countries: Bulgaria, Estonia, Germany, Hungary, Italy, Latvia, Lithuania, Poland, Portugal, Romania and Slovak Republic. Many generics entered the European market around 2011. It was never introduced to the United States market for any indication but in 2008, Adeona Pharmaceuticals, Inc. (now called Synthetic Biologics, Inc.) obtained an option to license issued and patent pending applications relating to flupirtine's use in the treatment of ophthalmic indications, particularly retinitis pigmentosa. As of 2016 it is marketed under many brand names, including Efiret, Flupigil, Flupirtin, Flupirtina, Flupirtine, Flupizen, Fluproxy, Katadolon, Metanor, Trancolong, and Zentiva.
Russian guided bomb and missile strikes on residential areas of Mykolaiv and Kherson injured at least 25 people, with three in serious condition. Local officials said apartment blocks, private residences, two schools, and a medical facility were damaged in the bombings. Another six were injured in a separate missile attack on a car service shop in Mykolaiv. The SBU arrested six people in Donetsk Oblast on suspicion of aiding Russian airstrikes. US Secretary of State Antony Blinken announced an additional $2 billion in aid, in addition to more ammunition, armoured vehicles, missiles, and air defences for Ukraine.
== Funding and infrastructure == Initial construction costs were covered by the ERDF and Czech state funds. Operational funding comes from competitive grants, including Czech Science Foundation (GACR) awards and Horizon Europe projects. The campus features a cogeneration plant and rainwater recycling systems.
=== Construction === To expedite the pre-construction work on the expressway, MSRDC decided to divide the design work into 5 packages and hired a separate consultancy firm to prepare the Detailed Project Report (DPR) for each package, On 31 May 2017, the Government of Maharashtra incorporated 'Nagpur Mumbai Super Communication Expressway Limited', a special purpose vehicle (SPV), to manage the financial requirement for the construction and operation of this project. The construction work of the 701 km long Mumbai–Nagpur Expressway is divided into 16 packages, with work awarded to 13 different contractors, including Afcons Infrastructure, Larsen & Toubro (L&T), and Reliance Infrastructure.
Sources: en.wikipedia.org
In November, Carrington destroyed villages adjacent to his line of communication and advanced towards Morija. In early December, he set up camp at Tsita's Nek, engaging in multiple clashes with the Basuto on the road to Morija. On 14 January 1881, Colonel Brabant led a force of 380 cavalry, 180 infantry, 400 armed burghers, and two 7-pounder guns towards Thaba Tsueu. Brabant sent the burghers ahead to capture the Radiamari village. After burning Radiamari, the burghers disregarded their orders and pushed further into Sepechele village, which was held by 8,000 men under Lerotholi. Chief Maama charged the burghers with 3,000 of his warriors, and the latter began to withdraw towards the rest of the Cape force. The Basuto managed to close in on the burghers but were eventually beaten off with carbine and artillery fire. As Maama retired, Lerotholi's warriors opened heavy fire from the surrounding ridges. Surgeon John Frederick McCrea of the 1st CMY won the Victoria Cross for attending injured burghers while being wounded himself. Brabant sent 140 riders from the Yeomanry in pursuit of Maama. The initial counter-attack failed after it was outflanked from the right. The Cape troops then dismounted and cleared the plateau and surrounding ridges. The Basuto suffered heavy casualties, while the Cape lost 16 killed and 21 wounded. Brabant then returned to his camp at Tsita's Nek. For most of the war the Cape's troops and administration remained isolated in the Hlotse, Maseru, and Mafeteng Districts. The lack of offensive action reduced the Cape troops' morale still further.
secondary structure The arrangement or folding of a polypeptide's primary structure into higher-order, locally organized structures, primarily via hydrogen bonding between non-adjacent amino acid residues, in particular α helices and β sheets; or the arrangement of double-stranded nucleic acid chains into the shape of a double helix stabilized by hydrogen bonds between the complementary bases.
6 – he won against Oscar Otte, Roman Safiullin, Laslo Đere, Kei Nishikori and Alejandro Davidovich Fokina. In the semifinal, he played Stefanos Tsitsipas, to whom he lost after a 5-set battle. Zverev's first appearance on grass started with a tournament at home in Halle – he lost in the second round to the eventual tournament winner Ugo Humbert. At Wimbledon, seeded No. 4, he equaled his best achievement at the tournament to date – reaching the fourth round for a second time. Along the way he defeated Tallon Griekspoor, Tennys Sandgren and Taylor Fritz. He was defeated in the fourth round by Félix Auger-Aliassime in five sets. Following this run he returned to the top 5 after 2 years on 12 July 2021. At the Olympics, Zverev beat Yen-hsun Lu, Daniel Elahi Galán, Nikoloz Basilashvili and Jérémy Chardy to reach the semifinals. In the semifinals, despite being a set and a break down against world No. 1 Novak Djokovic, Zverev rallied to break back and won eight games in a row on his way to win in three sets. He defeated Karen Khachanov in straight sets in the final to claim the Olympic gold medal. Zverev became the first German man to win a gold medal in singles and the first to win a medal since Tommy Haas won his silver medal at the 2000 Sydney Olympics. Following the Olympics, Zverev reached his second Masters 1000 final of the year at the 2021 Western & Southern Open after defeating Lloyd Harris, Guido Pella, Casper Ruud and Stefanos Tsitsipas after a close three-set battle in the semifinal. Zverev had not won a match at the tournament in six prior appearances.
Although the Cossacks were sometimes portrayed by Bolsheviks, and later by émigré historians, as a monolithic counterrevolutionary group during the civil war, there were many Cossacks who fought with the Red Army throughout the conflict, known as Red Cossacks. Many poorer Cossack communities also remained receptive to the communist message. In late 1918 and early 1919, widespread desertion and defection among Don, Ural, and Orenburg Cossacks fighting with the Whites produced a military crisis that was exploited by the Red Army in those sectors. After the main White armies were defeated in early 1920, many Cossack soldiers switched their allegiance to the Bolsheviks, and fought with the Red Army against the Poles and in other operations. On 22 December 1917, the Council of People's Commissars effectively abolished the Cossack estate by ending their military service requirements and privileges. After the widespread anticommunist rebellions among Cossacks in 1918, the Soviet regime's approach hardened in early 1919, when the Red Army occupied Cossack districts in the Urals and northern Don. The Bolsheviks embarked on a policy of "de-Cossackization", intended to end the Cossack threat to the Soviet regime. This was pursued through resettlement, widespread executions of Cossack veterans from the White armies, and favoring the outlanders within the Cossack hosts. Ultimately, the de-Cossackization campaign led to a renewed rebellion among Cossacks in Soviet-occupied districts and produced a new round of setbacks for the Red Army in 1919.
In 2026 Song and colleagues described Eoceras shaanxiense, a siphuncle-bearing cephalopod, based on fossils from the Early Cambrian Shuijingtuo Formation of China, making it the earliest known definitive cephalopod at the time of its discovery. Early cephalopods were likely predators near the top of the food chain. After the late Cambrian extinction led to the disappearance of many radiodonts, predatory niches became available for other animals. During the Ordovician period, the primitive cephalopods underwent pulses of diversification to become diverse and dominant in the Paleozoic and Mesozoic seas. In the Early Palaeozoic, their range was far more restricted; they were mainly confined to sublittoral regions of shallow shelves of the low latitudes, and usually occurred in association with thrombolites. A more pelagic habit was gradually adopted as the Ordovician progressed. Deep-water cephalopods, whilst rare, have been found in the Lower Ordovician – but only in high-latitude waters. The mid-Ordovician saw the first cephalopods with septa strong enough to cope with the pressures associated with deeper water, and could inhabit depths greater than 100–200 m. The direction of shell coiling would prove to be crucial to the future success of the lineages; endogastric coiling would only permit large size to be attained with a straight shell, whereas exogastric coiling – initially rather rare – permitted the spirals familiar from the fossil record to develop, with their corresponding large size and diversity.
Sources: en.wikipedia.org
No. Melanotan-2 is manufactured synthetically. The naturally occurring peptide in the same family is alpha-melanocyte-stimulating hormone, which the body produces as part of normal endocrine and neural signalling.
Both are synthetic analogues derived from the same parent hormone. Reference descriptions usually characterise afamelanotide as more selective for the MC1R subtype, whereas melanotan-2 is reported to interact with a wider range of melanocortin receptors.
Early studies explored melanocortin signalling and pigmentation, which later led to informal use of the label tanning peptide. That label is not a regulatory category and does not imply approved status for any purpose.
Low temperature slows hydrolysis and oxidation, the two main routes by which the peptide backbone and side chains are modified. A lyophilised powder stored at −20 °C is more stable than one kept at room temperature, and once the material is dissolved the degradation rate rises, making refrigeration more important.